Synthetic therapeutic gene circuits in mammalian cells (Q26826954)

language of work or name

1 reference

1 August 2014

1 reference

1 reference

588

1 reference

PubMed

issue

15

1 reference

PubMed

page(s)

2537-44

1 reference

Synthetic biology: integrated gene circuits

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Synthetic biology: exploring and exploiting genetic modularity through the design of novel biological networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Recent advances in mammalian synthetic biology-design of synthetic transgene control networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Synthetic biology: applications come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Construction of a genetic toggle switch in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A fast, robust and tunable synthetic gene oscillator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A synthetic oscillatory network of transcriptional regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A synthetic gene-metabolic oscillator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Diversity-based, model-guided construction of synthetic gene networks with predicted functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Synthetic gene networks that count

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A synchronized quorum of genetic clocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A synthetic genetic edge detection program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A synthetic multicellular system for programmed pattern formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Programmed population control by cell-cell communication and regulated killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Design of artificial cell-cell communication using gene and metabolic networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Engineering the perfect (bacterial) cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Production of the antimalarial drug precursor artemisinic acid in engineered yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

The food additive vanillic acid controls transgene expression in mammalian cells and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Synthetic mammalian trigger-controlled bipartite transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

An engineered mammalian band-pass network

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A designer network coordinating bovine artificial insemination by ovulation-triggered release of implanted sperms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Self-sufficient control of urate homeostasis in mice by a synthetic circuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Bile acid-controlled transgene expression in mammalian cells and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Macrolide-based transgene control in mammalian cells and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A red/far-red light-responsive bi-stable toggle switch to control gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Reward-based hypertension control by a synthetic brain-dopamine interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Insulin resistance and hyperglycaemia in cardiovascular disease development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Spatiotemporal control of gene expression by a light-switchable transgene system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Testosterone deficiency, insulin resistance and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Lifestyle change and mobility in obese adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Health and economic burden of the projected obesity trends in the USA and the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Metabolic syndrome meets osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Role of bile acids and bile acid receptors in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A common neurobiology for pain and pleasure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Food and drug reward: overlapping circuits in human obesity and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

The locus coeruleus and noradrenergic modulation of cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Overcoming implementation challenges of personalized cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A tunable dual-promoter integrator for targeting of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Multi-input RNAi-based logic circuit for identification of specific cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Reprogramming cellular behavior with RNA controllers responsive to endogenous proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Overview of gene therapy clinical progress including cancer treatment with gene-modified T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Adoptive immunotherapy for cancer: harnessing the T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Targeting natural killer cells and natural killer T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Cell-based therapeutics: the next pillar of medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

CD4(+)Foxp3(+) regulatory T cell therapy in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Regulatory T cell induction, migration, and function in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Raising the bar: the curative potential of human cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Synthetic biology moving into the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Synthetic mammalian gene circuits for biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Design of synthetic mammalian quorum-sensing systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

A synthetic low-frequency mammalian oscillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Synthetic two-way communication between mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Engineering of synthetic intercellular communication systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

G protein-coupled receptors revisited: therapeutic applications inspired by synthetic biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Improvement of the monitoring and biosafety of encapsulated cells using the SFGNESTGL triple reporter system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Smart medication through combination of synthetic biology and cell microencapsulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

mRNA transfection-based, feeder-free, induced pluripotent stem cells derived from adipose tissue of a 50-year-old patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

7 January 2021

Uric acid nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

7 January 2021

Programmable single-cell mammalian biocomputers

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

7 January 2021

Clinical practice. Gout

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

7 January 2021

Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.05.003

7 January 2021

10.1016/J.FEBSLET.2014.05.003

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_htxnubh7qraklog735fo6i4m6q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/htxnubh7qraklog735fo6i4m6q

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24844435

1 reference

Consolidated OpenCitations Corpus – April 2017